Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday
U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial results; several small caps also rallied.
Stocks · News reference
Wells Fargo analyst Ike Boruchow maintains Victoria's Secret (NYSE:VSXY) with a Overweight and raises the price target from $90 to $100.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial results; several small caps also rallied.
Victoria's Secret (VSXY) shares have declined 10% despite strong Q2 results showing 9% comparable sales growth, expanded margins, and positive customer trends. However, the stock trades above its historical valuation while facing headwinds from tariffs, transportation costs, and increased marketing spending. Analysts recommend a cautious approach, suggesting the pullback improves entry price but doesn't eliminate execution risks.